BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9228588)

  • 1. Decrease in CD4 lymphocyte counts with rest; implications for the monitoring of HIV infection.
    Campbell PJ; Aurelius S; Blowes G; Harvey D
    Int J STD AIDS; 1997 Jul; 8(7):423-6. PubMed ID: 9228588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute lymphocyte count as a marker for CD4 T-lymphocyte count: criterion for initiating antiretroviral therapy in HIV infected Nigerians.
    Erhabor O; Uko EK; Adias T
    Niger J Med; 2006; 15(1):56-9. PubMed ID: 16649453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important.
    Malone JL; Simms TE; Gray GC; Wagner KF; Burge JR; Burke DS
    J Acquir Immune Defic Syndr (1988); 1990; 3(2):144-51. PubMed ID: 1967309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine.
    Disla E; Rhim HR; Reddy A; Taranta A
    J Rheumatol; 1994 Apr; 21(4):662-4. PubMed ID: 7913502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
    Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
    J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis.
    Boulassel MR; Spurll G; Rouleau D; Tremblay C; Edwardes M; Sekaly RP; Lalonde R; Routy JP
    J Clin Apher; 2003; 18(2):55-60. PubMed ID: 12874816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.
    McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA
    Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects.
    Gordon CL; Cheng AC; Cameron PU; Bailey M; Crowe SM; Mills J
    PLoS One; 2015; 10(6):e0125248. PubMed ID: 26110761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
    Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
    JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of duration and temperature of sample preservation on the result of peripheral blood CD4+ and CD8+ T lymphocyte count in HIV/AIDS patients].
    Xiao Y; Zhang GY; Pei LJ; Zhang K; Zhang YH; Feng Y; Jiang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Jun; 18(2):129-31. PubMed ID: 15340499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons.
    Blatt SP; Lucey CR; Butzin CA; Hendrix CW; Lucey DR
    JAMA; 1993 Feb; 269(5):622-6. PubMed ID: 8093628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
    Schreibman T; Friedland G
    Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two staging systems for HIV infection for use in developing countries.
    Vandenbruaene M; Colebunders R; Goeman J; Alary M; Farber CM; Kestens L; van Ham G; Van den Ende J; Van Gompel A; Van den Enden E
    AIDS; 1993 Dec; 7(12):1613-5. PubMed ID: 7904453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Values of lymphocyte subsets in Nepalese healthy adult population.
    Shakya G; Dumre SP; Malla S; Sharma M; Kc KP; Chhetri DB; Amatya R; Paudyal P
    JNMA J Nepal Med Assoc; 2012; 52(185):6-13. PubMed ID: 23279766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons].
    Günthard H; Opravil M; Ledergerber B; Olsson K; Vogt M; Fierz W; Lüthy R
    Dtsch Med Wochenschr; 1993 May; 118(20):737-45. PubMed ID: 8099005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
    Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
    Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.